Your browser doesn't support javascript.
loading
Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.
Walle, Thomas; Bajaj, Sunanjay; Kraske, Joscha A; Rösner, Thomas; Cussigh, Christiane S; Kälber, Katharina A; Müller, Lisa Jasmin; Strobel, Sophia Boyoung; Burghaus, Jana; Kallenberger, Stefan M; Stein-Thöringer, Christoph K; Jenzer, Maximilian; Schubert, Antonia; Kahle, Steffen; Williams, Anja; Hoyler, Birgit; Zielske, Lin; Skatula, Renate; Sawall, Stefanie; Leber, Mathias F; Kunes, Russell Z; Krisam, Johannes; Fremd, Carlo; Schneeweiss, Andreas; Krauss, Jürgen; Apostolidis, Leonidas; Berger, Anne Katrin; Haag, Georg M; Zschäbitz, Stefanie; Halama, Niels; Springfeld, Christoph; Kirsten, Romy; Hassel, Jessica C; Jäger, Dirk; Ungerechts, Guy.
  • Walle T; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. t.walle@dkfz.de.
  • Bajaj S; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. t.walle@dkfz.de.
  • Kraske JA; German Cancer Consortium (DKTK), Heidelberg, Germany. t.walle@dkfz.de.
  • Rösner T; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cussigh CS; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Kälber KA; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Müller LJ; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Strobel SB; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Burghaus J; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Kallenberger SM; Department of Hematology, University Hospital Heidelberg, Heidelberg, Germany.
  • Stein-Thöringer CK; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Jenzer M; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Schubert A; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Kahle S; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Williams A; Division Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hoyler B; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Zielske L; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Skatula R; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Sawall S; BioQuant & Department of Cell and Molecular Biology, Heidelberg University, Heidelberg, Germany.
  • Leber MF; Division Signaling and Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kunes RZ; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Krisam J; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Fremd C; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schneeweiss A; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Krauss J; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Apostolidis L; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Berger AK; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Haag GM; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Zschäbitz S; Department of Statistics, Columbia University, New York, NY, USA.
  • Halama N; Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.
  • Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Kirsten R; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Hassel JC; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Jäger D; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Ungerechts G; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Nat Cancer ; 3(9): 1039-1051, 2022 09.
Article en En | MEDLINE | ID: mdl-35715501
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article